Archives for February 15, 2005

← 2005

Scientists discover signal KO's cause diabetes

US scientists have demonstrated that by knocking out two key signals in liver cells causes diabetes. These findings pave the way for drug strategies to boost these two different signals and treat the different metabolic components in sufferers.

Education system fails pharma industry

The UK education system is failing to provide sufficient high calibre scientists needed for the research-based pharmaceutical industry. The concern is that financial targets have meant university science departments becoming increasingly vulnerable to...

Thomson offers label conversion to meet new FDA regs

Thomson Scientific & Healthcare has launched a new service to allow pharmaceutical companies to quickly create and modify drug labels that comply with new US Food and Drug Administration guidance due to come into play this year.

Teva reports sales surge in 2004

Israeli drug and active pharmaceutical ingredients (API) company Teva has reported a sharp increase in sales in 2004, helped in part by last year's $3.4bn (€2.6bn) acquisition of Sicor.

Human microdose trial data encouraging

As the cost of commercialising drugs continues to spiral, results from a trial evaluating the concept of human microdosing is set to offer great potential in drug development. The pharmaceutical industry is placing importance in finding ways of...

Separation tech for oligo research

Two US companies have teamed up to market a separation technology that could improve the yield, purity and length of oligonucleotide sequences.